Invention Grant
- Patent Title: Method of treating autoimmune disease by administering antibodies to interleukin-6
-
Application No.: US15687085Application Date: 2017-08-25
-
Publication No.: US10370443B2Publication Date: 2019-08-06
- Inventor: Tong-Young Lee , Han-Chung Wu , Tanny Chen Tsao , Willie Lin
- Applicant: Fountain Biopharma Inc.
- Applicant Address: TW Taipei
- Assignee: Fountain Biopharma Inc.
- Current Assignee: Fountain Biopharma Inc.
- Current Assignee Address: TW Taipei
- Agency: Polsinelli
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24 ; A61K31/282 ; A61K31/337 ; A61K31/7068 ; A61K45/06 ; A61K39/00
Abstract:
The present disclosure provides antibodies that bind to human interleukin-6 (IL6). The antibodies can modulate IL6 signaling and thus used in treatment or prevention of IL6 associated diseases or disorders, particularly inflammatory disorder, rheumatoid arthritis (RA), angiogenesis, and cancer.
Public/Granted literature
- US20170362317A1 USES OF ANTIBODIES TO INTERLEUKIN-6 IN CANCER TREATMENT Public/Granted day:2017-12-21
Information query
